PanoramicaGraficoProfiloStatistiche chiaveDati finanziariTecnicoNotizieSchermataTrader

Fagron SA/  BE0003874915  /

Euronext - Brüssel
11/11/2024  17:35:15 Var. +0.260 Volume Denaro03:01:33 Lettera03:01:33 Capitalizzazione di mercato Dividend Y. Rapporto P/E
19.220EUR +1.37% 45,735
Fatturato: 877,299.840		 19.000Quantità in denaro: 15 19.300Quantità in lettera: 204 1.41 bill.EUR 1.56% 19.81
GlobeNewswire 30/01 MasterControl Launches Advanced Quality Event Management Software to Streamline Quality Processes
GlobeNewswire 07/10/2021 MasterControl Honors Customers’ Success in Quality and Innovation at the Annual Masters of Excellen...
GlobeNewswire 23/03/2021 Fagron Expands Use of MasterControl’s Quality Excellence to 8 European Sites
GlobeNewswire 26/06/2019 Fagron NV: Fagron reaches settlement in principle with US Department of Justice
GlobeNewswire 03/06/2019 U.S. Compounding Pharmacies Market is Expected to Reach Around US$ 14 Bn by the End of 2028 – Future...
GlobeNewswire 14/05/2019 Fagron NV: Fagron shareholders approve all proposed resolutions
GlobeNewswire 13/05/2019 Fagron NV: Fagron enters Mexican market with acquisition of Cedrosa
GlobeNewswire 12/04/2019 Convocation annual general meeting and extraordinary meeting
GlobeNewswire 12/04/2019 Fagron continued strong turnover growth in first quarter 2019
GlobeNewswire 11/04/2019 Fagron NV: Disclosure of received notification
GlobeNewswire 07/02/2019 Fagron realized turnover growth of 14.5%; REBITDA increased to € 99.1 million
GlobeNewswire 23/10/2018 Fagron NV: Disclosure of received notification
GlobeNewswire 11/10/2018 Fagron continues strong turnover growth of first semester in the third quarter of 2018
GlobeNewswire 18/09/2018 Compounding Pharmacies Market to Reach US$ 13,366.5 Mn by 2025 – Persistence Market Research
GlobeNewswire 31/08/2018 Fagron NV: Disclosure of received notification
GlobeNewswire 03/08/2018 Fagron realised organic turnover growth of 8.5%
GlobeNewswire 31/07/2018 Fagron NV : Disclosure of received notification
GlobeNewswire 12/07/2018 Sequana Medical Announces the Appointment of Kirsten Van Bockstaele as Chief Financial Officer
GlobeNewswire 26/06/2018 Fagron NV: Disclosure of received notifications
GlobeNewswire 15/05/2018 Fagron shareholders approve all proposed resolutions
GlobeNewswire 14/05/2018 Fagron NV: Disclosure of received notification
GlobeNewswire 13/04/2018 Fagron NV: Convocation annual general meeting and extraordinary general meeting
GlobeNewswire 12/04/2018 Fagron realises organic turnover growth of 6.8%
GlobeNewswire 03/04/2018 Fagron strengthens strategic position in USA through highly complementary acquisition of Humco
GlobeNewswire 07/02/2018 Fagron turnover increased by 3.6% to € 436.9 million and net profit increased to € 47.0 million